Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carmelina Antonella Iannuzzi
P53 Status as Effect Modifier of the Association Between Pre-Treatment Fasting Glucose and Breast Cancer Outcomes in Non Diabetic, HER2 Positive Patients Treated With Trastuzumab
Oncotarget
Oncology
Related publications
NT-proBNP Correlates With LVEF Decline in HER2-positive Breast Cancer Patients Treated With Trastuzumab
Cardio-Oncology
Trastuzumab Use in Older Patients With HER2-positive Metastatic Breast Cancer: Outcomes and Treatment Patterns in a Whole-Of-Population Australian Cohort (2003–2015)
BMC Cancer
Cancer Research
Oncology
Genetics
Trastuzumab as Adjuvant Treatment for Early Stage HER2-positive Breast Cancer — A 10 Year History
Nowotwory
Cancer Research
Oncology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine
Cancer Management and Research
Oncology
Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
